Yamashita, K., Igawa, W., Ono, M., Kido, T., Okabe, T., Yamamoto, M. H., . . . Ochiai, M. (2019). Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease. Kidney Dis (Basel).
Chicago Style CitationYamashita, Kennosuke, et al. "Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients With Heart Failure and Chronic Kidney Disease." Kidney Dis (Basel) 2019.
Cita MLAYamashita, Kennosuke, et al. "Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients With Heart Failure and Chronic Kidney Disease." Kidney Dis (Basel) 2019.
Atenció: Aquestes cites poden no estar 100% correctes.